| Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer (NCT01245205) | National Cancer Institute (NCI) | 2010-11-01 |
| RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer (NCT01149356) | National Cancer Institute (NCI) | 2010-10-01 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT01233505) | National Cancer Institute (NCI) | 2010-10-01 |
| Endoscopic Breast Surgery in Treating Patients With Breast Cancer (NCT01222377) | University of Southern California | 2010-09-01 |
| Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer (NCT01104259) | University of Washington | 2010-07-01 |
| Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload (NCT01159067) | City of Hope Medical Center | 2010-07-01 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258) | University of Southern California | 2010-06-01 |
| Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer (NCT01151449) | National Cancer Institute (NCI) | 2010-06-01 |
| RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors (NCT01158274) | National Cancer Institute (NCI) | 2010-06-01 |
| Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer (NCT01084057) | City of Hope Medical Center | 2010-05-17 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer (NCT01009983) | Wake Forest University Health Sciences | 2010-03-01 |
| Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer (NCT01051401) | Wake Forest University Health Sciences | 2010-01-01 |
| Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer (NCT01042535) | H. Lee Moffitt Cancer Center and Research Institute | 2009-12-28 |
| Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer (NCT00998738) | Mayo Clinic | 2009-11-01 |
| Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer (NCT01037790) | Abramson Cancer Center at Penn Medicine | 2009-10-01 |
| Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer (NCT04298333) | Meabco A/S | 2009-06-27 |
| Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer (NCT00821964) | University of Washington | 2008-12-01 |
| Vaccine Therapy in Treating Patients With Stage IV Breast Cancer (NCT00791037) | University of Washington | 2008-10-01 |
| F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer (NCT00602043) | National Cancer Institute (NCI) | 2008-09-01 |
| Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant (NCT00795769) | Fred Hutchinson Cancer Center | 2008-08-08 |
| Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer (NCT00733408) | University of Washington | 2008-04-23 |
| Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU (NCT00520975) | National Cancer Institute (NCI) | 2007-11-01 |
| Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery (NCT00559507) | National Cancer Institute (NCI) | 2007-10-01 |
| Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer (NCT00577122) | Indiana University | 2007-07-01 |
| Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer (NCT00509587) | National Cancer Institute (NCI) | 2007-06-01 |
| VEGF Trap in Treating Patients With Metastatic Breast Cancer (NCT00369655) | National Cancer Institute (NCI) | 2007-01-01 |
| Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer (NCT00368875) | National Cancer Institute (NCI) | 2006-07-01 |
| AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery (NCT00348699) | National Cancer Institute (NCI) | 2006-07-01 |
| Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant (NCT00408681) | Fred Hutchinson Cancer Center | 2006-06-01 |
| Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer (NCT00331552) | University of Washington | 2006-02-01 |
| Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer (NCT00182767) | National Cancer Institute (NCI) | 2006-01-01 |
| ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment (NCT00425672) | University of Washington | 2005-09-01 |
| A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202) (NCT00244881) | National Cancer Institute (NCI) | 2005-09-01 |
| Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer (NCT00096109) | National Cancer Institute (NCI) | 2005-09-01 |
| Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer (NCT00100750) | National Cancer Institute (NCI) | 2005-09-01 |
| Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients (NCT00316407) | Swedish Medical Center | 2005-08-01 |
| Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer (NCT00217399) | National Cancer Institute (NCI) | 2005-06-01 |
| Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen (NCT00118157) | National Cancer Institute (NCI) | 2005-05-01 |
| Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer (NCT00077376) | National Cancer Institute (NCI) | 2005-03-01 |
| FR901228 in Treating Patients With Metastatic Breast Cancer (NCT00098397) | National Cancer Institute (NCI) | 2005-02-01 |
| 3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer (NCT00095888) | National Cancer Institute (NCI) | 2004-10-01 |
| Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases (NCT00098605) | National Cancer Institute (NCI) | 2004-10-01 |
| Sorafenib in Treating Patients With Metastatic Breast Cancer (NCT00096434) | National Cancer Institute (NCI) | 2004-09-01 |
| Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer (NCT00077363) | National Cancer Institute (NCI) | 2004-05-01 |
| Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer (NCT00082810) | National Cancer Institute (NCI) | 2004-03-01 |
| Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer (NCT00343109) | University of Washington | 2004-03-01 |
| Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer (NCT00079326) | National Cancer Institute (NCI) | 2004-01-01 |
| GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer (NCT00068588) | National Cancer Institute (NCI) | 2003-10-01 |
| Vaccine Therapy in Treating Patients With Metastatic Breast Cancer (NCT00071942) | National Cancer Institute (NCI) | 2003-10-01 |
| Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine (NCT00228358) | University of Washington | 2003-06-01 |
| Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer (NCT00063934) | National Cancer Institute (NCI) | 2003-05-01 |
| Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer (NCT00060372) | National Cancer Institute (NCI) | 2003-04-01 |
| Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer (NCT00054132) | National Cancer Institute (NCI) | 2002-12-01 |
| Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer (NCT00045188) | National Cancer Institute (NCI) | 2002-08-01 |
| Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer (NCT00055861) | National Cancer Institute (NCI) | 2002-07-01 |
| Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer (NCT00039455) | National Cancer Institute (NCI) | 2002-04-01 |
| Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer (NCT00024154) | National Cancer Institute (NCI) | 2002-02-01 |
| Decitabine in Treating Patients With Advanced Solid Tumors (NCT00030615) | National Cancer Institute (NCI) | 2001-12-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496) | National Cancer Institute (NCI) | 2001-11-01 |
| A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer (NCT00378313) | NSABP Foundation Inc | 2001-11-01 |
| Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer (NCT00436254) | University of Washington | 2001-10-01 |
| Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer (NCT00146549) | Dana-Farber Cancer Institute | 2001-08-01 |
| PS-341 in Treating Women With Metastatic Breast Cancer (NCT00025584) | National Cancer Institute (NCI) | 2001-08-01 |
| Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer (NCT00016276) | National Cancer Institute (NCI) | 2001-05-01 |
| Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer (NCT00017394) | National Cancer Institute (NCI) | 2001-03-01 |
| Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer (NCT00004888) | National Cancer Institute (NCI) | 2001-01-01 |
| Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer (NCT00006228) | National Cancer Institute (NCI) | 2000-07-01 |
| Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer (NCT00005817) | National Cancer Institute (NCI) | 2000-03-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic (NCT00003440) | National Cancer Institute (NCI) | 1998-07-01 |
| Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer (NCT00003199) | Fred Hutchinson Cancer Center | 1997-11-01 |
| Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer (NCT00003454) | Burzynski Research Institute | 1996-03-18 |
| Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer (NCT00003536) | Burzynski Research Institute | |
| Antineoplaston Therapy in Treating Women With Advanced Breast Cancer (NCT00003455) | Burzynski Research Institute | |
| Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer (NCT00053339) | Alliance for Clinical Trials in Oncology | |